Importance of drug transporters in pharmacokinetics and drug safety

被引:6
作者
Ward, Peter [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, DMPK Dept, San Diego, CA 92121 USA
关键词
transporters; drug-drug interactions; drug elimination; toxicity; pharmacology; pharmacokinetics; P-glycoprotein;
D O I
10.1080/15376510701795306
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The exact role of transporters in the absorption, distribution, and excretion (ADE) of drugs is still being elucidated; however, current evidence suggests that their role in these processes may be significant. In this review, the role of transporters in the ADE, pharmacology, toxicology, and clinical drug-drug interactions (DDIs) of drugs will be discussed. The current biological tools to assess this role and practical perspectives for the utilization of knowledge about drug transporters to drug discovery and development will also be discussed. Currently, regulatory agencies are focusing on these potential transporter-mediated DDIs. Therefore, guidance and caution on the investigation of these DDIs will be given.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [21] Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance
    Zamek-Gliszczynski, Maciej J.
    Taub, Mitchell E.
    Chothe, Paresh P.
    Chu, Xiaoyan
    Giacomini, Kathleen M.
    Kim, Richard B.
    Ray, Adrian S.
    Stocker, Sophie L.
    Unadkat, Jashvant D.
    Wittwer, Matthias B.
    Xia, Cindy
    Yee, Sook-Wah
    Zhang, Lei
    Zhang, Yan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 890 - 899
  • [22] ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
    Choi, Young Hee
    Yu, Ai-Ming
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (05) : 793 - 807
  • [23] Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox
    Lacroix, Clemence
    Guilhaumou, Romain
    Micallef, Joelle
    Blin, Olivier
    THERAPIE, 2024, 79 (03): : 351 - 363
  • [24] The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development
    Moore, Kenneth T.
    Zannikos, Peter N.
    Masters, Joanna C.
    Willmann, Stefan
    Shen, Jinshan
    Frost, Charles
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 : S78 - S84
  • [25] Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics
    Fardel, Olivier
    Kolasa, Elise
    Le Vee, Marc
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (01) : 29 - 46
  • [26] Pharmacokinetics, Drug Metabolism, and Safety of Prasugrel and Clopidogrel
    Achar, Suraj
    POSTGRADUATE MEDICINE, 2011, 123 (01) : 73 - 79
  • [27] Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes
    Mariappan, T. Thanga
    Shen, Hong
    Marathe, Punit
    CURRENT DRUG METABOLISM, 2017, 18 (08) : 757 - 768
  • [28] Multidrug transporters as drug targets
    Liang, X. -J.
    Aszalos, A.
    CURRENT DRUG TARGETS, 2006, 7 (08) : 911 - 921
  • [29] Current trends in drug metabolism and pharmacokinetics
    Yuhua Lia
    Qiang Meng
    Mengbi Yang
    Dongyang Liu
    Xiangyu Hou
    Lan Tang
    Xin Wang
    Yuanfeng Lyu
    Xiaoyan Chen
    Kexin Liu
    Ai-Ming Yu
    Zhong Zuo
    Huichang Bi
    Acta Pharmaceutica Sinica B, 2019, 9 (06) : 1113 - 1144
  • [30] Drug Metabolism and Pharmacokinetics in Support of Drug Design
    Tang, Wei
    Lu, Anthony Y. H.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (19) : 2170 - 2183